- Home
- USAS vs ATAI Comparison
USAS vs ATAI Comparison
Compare USAS & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAS
- ATAI
- Stock Information
- Founded
- USAS 1998
- ATAI 2018
- Country
- USAS Canada
- ATAI Germany
- Employees
- USAS N/A
- ATAI N/A
- Industry
- USAS Metal Mining
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- USAS Basic Materials
- ATAI Health Care
- Exchange
- USAS Nasdaq
- ATAI Nasdaq
- Market Cap
- USAS 386.9M
- ATAI 282.6M
- IPO Year
- USAS N/A
- ATAI 2021
- Fundamental
- Price
- USAS $0.59
- ATAI $1.41
- Analyst Decision
- USAS Strong Buy
- ATAI Strong Buy
- Analyst Count
- USAS 1
- ATAI 3
- Target Price
- USAS $1.00
- ATAI $10.50
- AVG Volume (30 Days)
- USAS 1.5M
- ATAI 1.4M
- Earning Date
- USAS 05-19-2025
- ATAI 05-19-2025
- Dividend Yield
- USAS N/A
- ATAI N/A
- EPS Growth
- USAS N/A
- ATAI N/A
- EPS
- USAS N/A
- ATAI N/A
- Revenue
- USAS $100,188,000.00
- ATAI $308,000.00
- Revenue This Year
- USAS $45.78
- ATAI $65.58
- Revenue Next Year
- USAS $17.98
- ATAI N/A
- P/E Ratio
- USAS N/A
- ATAI N/A
- Revenue Growth
- USAS 18.02
- ATAI N/A
- 52 Week Low
- USAS $0.21
- ATAI $1.03
- 52 Week High
- USAS $0.65
- ATAI $2.57
- Technical
- Relative Strength Index (RSI)
- USAS 52.55
- ATAI 44.57
- Support Level
- USAS $0.55
- ATAI $1.36
- Resistance Level
- USAS $0.64
- ATAI $1.54
- Average True Range (ATR)
- USAS 0.05
- ATAI 0.09
- MACD
- USAS -0.00
- ATAI -0.00
- Stochastic Oscillator
- USAS 60.67
- ATAI 0.00
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.